Danaher Corporation (NYSE: DHR) is a healthcare company, listed on the NYSE. Alpha Stocks Insight has published 2 articles on DHR since Tuesday, July 21, 2026, most recently "Danaher (NYSE: DHR) Names Julie Sawyer Montgomery CEO, Effective October 1" on Monday, August 3, 2026. Coverage to date spans Health Care and Earnings Report, tracking DHR's earnings, analyst activity, and material corporate events. New coverage is added each trading day.
Danaher's board tapped its Diagnostics chief to lead the company, replacing Rainer Blair who retires Oct. 1 after guiding a major portfolio transformation.
DHR adjusted EPS of $1.94 beat the $1.85 estimate by 4.7%, but bioprocessing timing and a -10.99% share move signal investor caution despite raised full-year guidance.
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.
Important Legal Disclaimer: This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.